News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Gastrologix and Cardinal Health Specialty Solutions Announce Agreement to Provide Distribution Services to GPO Members
10/26/2021

Paoli, PA — Cardinal Health Specialty Solutions and Gastrologix, the only gastroenterology (GI)-specific group purchasing organization (GPO) in the United States, working in conjunction with the Digestive Health Network (DHN), have announced an agreement which designates Cardinal Health’s Metro Medical business as the primary supplier of pharmaceutical products for Gastrologix GPO and DHN members, providing expanded access to critical medicines for GI patients nationwide.

“Gastrologix is a leader in providing technology and practice management solutions to the GI market. We are excited to marry their solutions with our best-in-class distribution capabilities to support the unique needs of independent gastroenterology practices, enabling providers to focus their time on positively impacting patient care,” said Dan Duran, Senior Vice President and General Manager, Provider Solutions, Cardinal Health Specialty Solutions.

“Independent GI practices face many challenges in working to provide high quality care at lower costs. The members of our GPO deal daily with healthcare consolidation, rising costs and declining reimbursements, ” said Stephen Somers, Principal at Gastrologix. “Cardinal Health Specialty Solutions is the perfect partner because they believe in tailoring programs to the individual needs of a practice and its patients. We look forward to working with them to provide our members with optimal contract pricing on specialty medications, as well as data analytics and specialized expertise. Our partnership with Cardinal Health will help our member practices thrive.”

Cardinal Health has one of the largest healthcare supply chains in the U.S. with strategically located distribution centers that enable fast and efficient delivery anywhere in the U.S. Through Specialty Solutions, Cardinal Health supports community-based practices across the nation with specialties in oncology, urology, nephrology, rheumatology, gastroenterology, ophthalmology, neurology, and immunology.

About Gastrologix
Gastrologix is the only Group Purchasing Organization (GPO) in the U.S. working strictly on behalf of independent gastroenterologists. Gastrologix helps practices lower costs, operate more efficiently and expand services, so that GI physicians can remain independent to provide a valuable healthcare alternative.

About Cardinal Health
Cardinal Health (NYSE: CAH) is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Contacts
Media: Marcia Frederick, marcia.frederick@cardinalhealth.com and (614) 757-9968
Investors: Kevin Moran, kevin.moran@cardinalhealth.com and (614) 757-7942

More Company News
04/22/2024

Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its...

04/02/2024

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

03/26/2024

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

03/15/2024

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

View all company news »